TrialInternational journal of radiation oncology, biology, physics2023

Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.

Andreas Rimner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.